ロード中...
Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)
BACKGROUND: Preoperative imatinib mesylate (IM) treatment has not yet been standardized. Here, we aim to further explore such therapy on patients with gastrointestinal stromal tumors (GIST) retrospectively. METHODS: Patients experiencing preoperative IM were identified from January 2009 to February...
保存先:
| 出版年: | World J Surg Oncol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5387273/ https://ncbi.nlm.nih.gov/pubmed/28399894 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-017-1143-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|